BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24060750)

  • 1. Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: implication of reconstituted tumor microenvironment and multidrug resistance phenotype.
    Kant S; Kumar A; Singh SM
    Biochim Biophys Acta; 2014 Jan; 1840(1):294-302. PubMed ID: 24060750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid synthase inhibitor orlistat induces apoptosis in T cell lymphoma: role of cell survival regulatory molecules.
    Kant S; Kumar A; Singh SM
    Biochim Biophys Acta; 2012 Nov; 1820(11):1764-73. PubMed ID: 22877747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
    Kumar A; Kant S; Singh SM
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelopoietic efficacy of orlistat in murine hosts bearing T cell lymphoma: implication in macrophage differentiation and activation.
    Kant S; Kumar A; Singh SM
    PLoS One; 2013; 8(12):e82396. PubMed ID: 24349275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell density-dependent alterations in tumorigenic potential of a murine T-cell lymphoma: implication in the evolution of multidrug resistance in tumor cells.
    Singh V; Singh MP; Singh SM
    Anticancer Drugs; 2008 Sep; 19(8):793-804. PubMed ID: 18690091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model.
    Bastos DC; Paupert J; Maillard C; Seguin F; Carvalho MA; Agostini M; Coletta RD; Noël A; Graner E
    Lab Invest; 2017 Feb; 97(2):194-206. PubMed ID: 27918556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of curcumin-dependent modulation of tumor microenvironment of a murine T cell lymphoma in altered regulation of tumor cell survival.
    Vishvakarma NK; Kumar A; Singh SM
    Toxicol Appl Pharmacol; 2011 May; 252(3):298-306. PubMed ID: 21397623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-neoplastic action of aspirin against a T-cell lymphoma involves an alteration in the tumour microenvironment and regulation of tumour cell survival.
    Kumar A; Vishvakarma NK; Tyagi A; Bharti AC; Singh SM
    Biosci Rep; 2012 Feb; 32(1):91-104. PubMed ID: 21692746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas.
    Seguin F; Carvalho MA; Bastos DC; Agostini M; Zecchin KG; Alvarez-Flores MP; Chudzinski-Tavassi AM; Coletta RD; Graner E
    Br J Cancer; 2012 Sep; 107(6):977-87. PubMed ID: 22892389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model.
    Carvalho MA; Zecchin KG; Seguin F; Bastos DC; Agostini M; Rangel AL; Veiga SS; Raposo HF; Oliveira HC; Loda M; Coletta RD; Graner E
    Int J Cancer; 2008 Dec; 123(11):2557-65. PubMed ID: 18770866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of phosphodiesterase 5 by sildenafil reduces tumor growth and potentiates tumor-killing ability of cisplatin in vivo against T cell lymphoma: Implication of modulated apoptosis, reactive oxygen species homeostasis, glucose metabolism, and pH regulation.
    Rawat SG; Tiwari RK; Kumar A
    Environ Toxicol; 2024 Apr; 39(4):1909-1922. PubMed ID: 38059649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bicarbonate transport inhibitor SITS modulates pH homeostasis triggering apoptosis of Dalton's lymphoma: implication of novel molecular mechanisms.
    Kant S; Kumar A; Singh SM
    Mol Cell Biochem; 2014 Dec; 397(1-2):167-78. PubMed ID: 25123669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs.
    Singh V; Singh SM
    Anticancer Drugs; 2007 Nov; 18(10):1123-32. PubMed ID: 17893512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid synthase inhibitors induce apoptosis in non-tumorigenic melan-a cells associated with inhibition of mitochondrial respiration.
    Rossato FA; Zecchin KG; La Guardia PG; Ortega RM; Alberici LC; Costa RA; Catharino RR; Graner E; Castilho RF; Vercesi AE
    PLoS One; 2014; 9(6):e101060. PubMed ID: 24964211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tumour stage-dependent evolution of drug resistant T cell lymphoma: role of soluble mediators of tumour and host origin.
    Singh V; Singh SM
    Leuk Res; 2009 May; 33(5):700-9. PubMed ID: 18930317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity.
    Kridel SJ; Axelrod F; Rozenkrantz N; Smith JW
    Cancer Res; 2004 Mar; 64(6):2070-5. PubMed ID: 15026345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperglycemia of tumor microenvironment modulates stage-dependent tumor progression and multidrug resistance: implication of cell survival regulatory molecules and altered glucose transport.
    Vishvakarma NK; Kumar A; Singh V; Singh SM
    Mol Carcinog; 2013 Dec; 52(12):932-45. PubMed ID: 22566271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer.
    Bauerschlag DO; Maass N; Leonhardt P; Verburg FA; Pecks U; Zeppernick F; Morgenroth A; Mottaghy FM; Tolba R; Meinhold-Heerlein I; Bräutigam K
    J Transl Med; 2015 May; 13():146. PubMed ID: 25947066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer.
    Ye S; Yang W; Wang Y; Ou W; Ma Q; Yu C; Ren J; Zhong G; Shi H; Yuan Z; Su X; Zhu W
    Int J Mol Med; 2013 Jan; 31(1):33-42. PubMed ID: 23128378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal.
    Chuang HY; Chang YF; Hwang JJ
    Biomed Pharmacother; 2011 Jul; 65(4):286-92. PubMed ID: 21723078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.